Description
Post-Transplant Diabetes Mellitus (PTDM) and obesity are frequent complications after renal transplantation. PTDM affects up to 30% of renal transplant recipients, which doubles the prevalence of type 2 diabetes observed in the general population. The consequences of PTDM are severe: it is associated with a reduced patient survival, high risk of infections and cardiovascular disease, diminishes quality of life and increases health care expenditure. Obesity, particularly associated with metabolic syndrome -metabolically unhealthy obesity- is frequent after transplantation and is associated with increased risk for allograft dysfunction. In this CME we will evaluate diverse aspects of PTDM and obesity including: pathogenesis, impact, long-term evolution and treatment, as well as the consequences of obesity and metabolic syndrome in renal transplantation.
Course content